KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Asset Writedowns and Impairment (2016 - 2019)

Astrana Health (ASTH) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with -$2.0 million as the latest value for Q4 2019.

  • Quarterly Asset Writedowns and Impairment fell 152.47% to -$2.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Sep 2020, down 145.0% year-over-year, with the annual reading at $422000.0 for FY2023, N/A changed from the prior year.
  • Asset Writedowns and Impairment hit -$2.0 million in Q4 2019 for Astrana Health, down from $2.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.8 million in Q4 2018 to a low of -$2.3 million in Q2 2019.
  • Historically, Asset Writedowns and Impairment has averaged $256773.6 across 5 years, with a median of $160633.0 in 2016.
  • Biggest YoY gain for Asset Writedowns and Impairment was 284.86% in 2019; the steepest drop was 152.47% in 2019.
  • Year by year, Asset Writedowns and Impairment stood at $126367.0 in 2015, then rose by 27.12% to $160633.0 in 2016, then plummeted by 48.08% to $83395.0 in 2017, then skyrocketed by 4456.63% to $3.8 million in 2018, then plummeted by 152.47% to -$2.0 million in 2019.
  • Business Quant data shows Asset Writedowns and Impairment for ASTH at -$2.0 million in Q4 2019, $2.0 million in Q3 2019, and -$2.3 million in Q2 2019.